Immunopathogenesis of hepatitis B virus recurrence after liver transplantation.

BACKGROUND AND AIMS Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation is associated with inflammatory graft changes, despite immunosuppression and donor/recipient HLA mismatch. We investigated whether immune mechanisms are involved in the pathogenesis of hepatitis B after liver transplantation. METHODS The virus-specific T helper (Th) cell response, activation of Th1/Th2 subpopulations, donor/recipient HLA, and expression of tumor necrosis factor (TNF)-alpha/TNF receptors were determined in 28 patients who underwent transplantation for HBV-related cirrhosis (17 with HBV recurrence and 11 without recurrence) in comparison to 30 nontransplant patients with chronic hepatitis B. RESULTS Orthotopic liver transplantation recipients with HBV recurrence showed significant hepatitis B core antigen-specific T-cell proliferation, comparable to nontransplant patients, which was not present in transplant recipients without recurrence. In addition, hepatic and serum interleukin (IL)-2, interferon-gamma, and TNF-alpha were enhanced, without changes in IL-4 and IL-10. Phenotypically, hepatic infiltrates in allografts with HBV recurrence were comprised of CD4+ lymphocytes and macrophages with a correlation between interferon-gamma- and TNF-alpha-producing cells and the degree of necroinflammatory activity. There was a marked up-regulation of both TNF-alpha receptors, significantly greater than in nontransplant patients. CONCLUSIONS These findings suggest that despite immunosuppression, HLA class I-independent immune mechanisms have a significant pathogenic role in liver damage associated with HBV recurrence after liver transplantation.

[1]  B. Portmann,et al.  Long-term outcome of hepatitis C infection after liver transplantation. , 1996, The New England journal of medicine.

[2]  M. Feldmann,et al.  Cytokines in autoimmunity. , 1992, Current opinion in immunology.

[3]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[4]  M. Hussain,et al.  Induction of T‐helper cell response to hepatitis B core antigen in chronic hepatitis B: A major factor in activation of the host immune response to the hepatitis B virus , 1995, Hepatology.

[5]  P. Debré,et al.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Gerken,et al.  Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutants , 1995, Hepatology.

[7]  P. Angus,et al.  Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro , 1995, Hepatology.

[8]  U. Spengler,et al.  Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection , 1995, Journal of virology.

[9]  B. Portmann,et al.  Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. , 1995, Gastroenterology.

[10]  T. Starzl,et al.  The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. , 1995, Transplantation.

[11]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[12]  W. Bechstein,et al.  Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. , 1994, Transplantation.

[13]  P. Scheurich,et al.  TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. , 1994, Journal of immunology.

[14]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[15]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[16]  M. Hussain,et al.  Cellular expression of tumour necrosis factor-α and interferon-γ in the liver biopsies of children with chronic liver disease , 1994 .

[17]  G. Alexander,et al.  Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.

[18]  F. Chisari,et al.  Human leukocyte antigen class I‐independent pathways may contribute to hepatitis B virus‐induced liver disease after liver transplantation , 1993, Hepatology.

[19]  B. Portmann,et al.  Influence of human leukocyte antigen matching on liver allograft survival and rejection: “The dualistic effect” , 1993, Hepatology.

[20]  R. Billings,et al.  Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes. , 1993, Toxicology and applied pharmacology.

[21]  F. Chisari,et al.  HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon‐γ , 1992 .

[22]  M. Sherman,et al.  Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. , 1992, The American journal of pathology.

[23]  G. Alexander,et al.  Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. , 1992, Transplantation.

[24]  S. Davies,et al.  High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. , 1992, Gastroenterology.

[25]  V. Desmet,et al.  Hepatic expression of type A and type B receptors for tumor necrosis factor. , 1992, Journal of hepatology.

[26]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.

[27]  S. Davies,et al.  Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.

[28]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.

[29]  F. Chisari,et al.  HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Ishikawa,et al.  Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ , 1991 .

[31]  G. Alexander,et al.  Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. , 1991, Journal of hepatology.

[32]  J. Lanchbury,et al.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. , 1991, Journal of immunology.

[33]  R Williams,et al.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis , 1991, Hepatology.

[34]  A Valli,et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.

[35]  B. Dousset,et al.  HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation. , 1990, Transplantation proceedings.

[36]  D. V. van Thiel,et al.  Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. , 1990, The American journal of pathology.

[37]  R. Palmiter,et al.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. , 1990, Science.

[38]  M. Mizokami,et al.  Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. , 1990, Journal of clinical pathology.

[39]  K. Yoshioka,et al.  Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease , 1989 .

[40]  R. Cotran,et al.  Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. , 1989, The American journal of pathology.

[41]  W. Müller,et al.  Interferon production in patients infected with HIV-1. , 1989, The Journal of infectious diseases.

[42]  F. Chisari,et al.  Hepatitis B virus structure and biology. , 1989, Microbial pathogenesis.

[43]  Prof. Dr. med. Gustav Steinhoff,et al.  Patterns of macrophage immigration and differentiation in human liver grafts. , 1989, Transplantation proceedings.

[44]  M. Feldmann,et al.  HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin , 1987, Nature.

[45]  S. Poppema,et al.  EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS AND REPLACEMENT OF DONOR CELLS BY RECIPIENT ONES IN HUMAN LIVER GRAFTS , 1987, Transplantation.

[46]  A. Thiede,et al.  Replacement of donor Kupffer cells by recipient cells after orthotopic rat liver transplantation. , 1987, Transplantation proceedings.

[47]  J. Hoofnagle,et al.  Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis , 1986, Hepatology.

[48]  T. Merigan,et al.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.